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Alzheimer’s Disease (AD) is a type of 
neurodegenerative disease of the brain, just as 
Coronary Artery Disease (CAD) is a disease related to 
the heart. Due to its progressive nature, its symptoms 
worsen with time. AD is thought to begin 20 years or 
more before symptoms arise.1,2 
 
It initiates itself as changes in the brain that are 
unnoticeable to the person affected. It is only after 
years of such changes that individuals experience 
noticeable symptoms such as memory loss and/or 
language problems. These symptoms occur due to the 
fact that the nerve cells (neurons) of the brain that 
are associated with thinking, learning and memory 
(cognitive function) have been damaged or destroyed 
beyond repair.  
 
Its progression affects neurons in other parts of the 
brain and eventually, neurons responsible for a 
person to carry out basic bodily functions, such as 
walking and swallowing are affected. Individuals 
become bed-bound and require around-the-clock 
care and its ultimately leads to demise of the patient.3 
 
ALZHEIMER’S DISEASE OR DEMENTIA?  
It is common for people to wonder the difference 
between AD and dementia. The term “dementia” 
refers to an overall term for a particular group of 
symptoms and its characteristic symptoms include 
difficulties with memory, language, problem-solving 
and other thinking skills affecting a person's ability to 
perform routine day-to-day activities.  In this context, 
AD is the most common cause of dementia. Infact, 
Alzheimer’s dementia refers to dementia that is 
caused by, or believed to be caused due to the brain 
changes of a person suffering from Alzheimer’s 
disease. Various studies have reported that episodic 
impairment of memory (amnesia) is prominently the 








It has been estimated that by the year 2050, the 
number of people age 65 and older with AD in the 
USA alone is projected to reach 12.7 million.3 In India, 
there were an estimated 3.7 million people suffering 
from dementia in 2010 and the grim situation is that 
it is projected to rise to approximately 7.6 million by 
the year 2030 with its awareness remaining low 
throughout the country.4 
 
Even within the field of medicine, research in 
dementia and related diseases remain low. Most of 
our existing knowledge and estimates of the 
incidence of dementia come from small regional case 
studies.4 There are, however, somewhat rare 
instances, particularly in younger patients (e.g., less 
than 65 years old), where AD initially presents with 
dementia dominated by higher-order visual 
dysfunction, executive dysfunction or deficits in 
language. The nature of AD is such that it may the 
prime cause of even more deaths than recognized and 
reported by official sources and the main reason for 
this is either its being considered as an “age” related 
change or inability to afford its treatment. AD is also 
a primal cause leading to disability as well as poor 
health among older adults as a person lives through 
years of morbidity as the disease progresses and till 
the time the patient dies.3 
 
To raise awareness regarding this important disease, 
September 21st every year is World Alzheimer’s Day 
around the world. This is an international campaign 
aimed at raising awareness and challenge the 
common stigma that surrounds Alzheimer related 
dementia. 
 
September 2021 marks the 10th world Alzheimer’s 
month since the campaign was launched in 2012. 
From previous studies, an average of 2 out of 3 people 
globally have little or no understanding of 
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